Tag: ACADIA Pharmaceuticals
October 15, 2019
Pharma Market Update: Q3 2019 in Review
With Q3 2019 officially over, the Investing News Network shares a pharma market update on the biggest news and trends...
May 28, 2019
8 Small Biotech ETFs
Want to invest in small biotech ETFs? Here we profile eight that life science investors may want to look into. October 31, 2018
ACADIA Pharmaceuticals Announces Positive Top-line Results from Phase 2 CLARITY Trial
ACADIA Pharmaceuticals (Nasdaq:ACAD) today announced positive top-line results from CLARITY, a randomized, double-blind, placebo-controlled, multi-center, sequential parallel comparison design (SPCD)... August 7, 2018
ACADIA Pharmaceuticals and Neuren Pharmaceuticals Announce Exclusive License Agreement
ACADIA Pharmaceuticals (NASDAQ:ACAD) and Neuren Pharmaceuticals (ASX:NEU) announced today that they have entered into an exclusive North American License Agreement...
July 10, 2018
Pharmaceutical Update: Q2 2018 in Review
With Q2 officially behind us and Q3 already in full swing, here the Investing News Network is providing a look... June 29, 2018
ACADIA Pharmaceuticals Announces FDA Approval of New Dosing Formulation and Strength for NUPLAZID (Pimavanserin)
ACADIA Pharmaceuticals (Nasdaq:ACAD) today announced FDA approval of a new capsule dose formulation and a new tablet strength of NUPLAZID... February 19, 2018